Something is shifting in how biotech gets built. For a decade, founders with a narrative problem have been offered two options: hire an agency, or hire a consultant. Agencies execute. Consultants advise. Both sit outside the room.
But the moments that actually define a biotech company don't happen in a retainer call or a deliverable. The narrative before a Series B. The positioning before a launch. The story before a partnership. The investor deck three weeks before a term sheet. They happen between the CEO and the CSO, in the conversations no one schedules, while they are still trying to figure out what they believe.
That room is where narrative is actually made. Until now, no one was built to sit in it.
Kizuna exists to sit in it. A founder office extension. A new category between agency and chief of staff, working inside the founding team on the story, the positioning, and the communication that carry the company through the moments that matter most.
We don't show up with a campaign. We show up with the founders. In the room.
This is a new shape of work for a new shape of company.